Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference
Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference
YARDLEY, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the Piper Sandler 36th Annual Healthcare Conference on December 5, 2024 at 1:30 p.m. ET.
賓夕法尼亞州雅德利，2024年12月02日(GLOBE NEWSWIRE) — 藥品公司optinose(NASDAQ:OPTN)，一家專注於耳鼻喉（ENT）和過敏專家治療的藥品公司，今天宣佈其管理團隊成員將於2024年12月5日下午1:30在派傑投資第36屆年度醫療保健大會上介紹公司資料和業務更新。
To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.
要收聽演示的網上直播，請訪問Optinose網站的投資者頁面。
A replay of the webcast will be available for 30 days following the conclusion of the event.
活動結束後的30天內，將提供網上直播的重播。
About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit or follow us on X and LinkedIn.
關於Optinose：Optinose是一家專注於爲耳鼻喉（ENT）和過敏專科醫生服務的專業製藥公司。欲了解更多信息，請訪問網站（）或關注我們的X和LinkedIn。
Optinose是一家專注於爲耳鼻喉（ENT）和過敏專科患者服務的專業製藥公司。想了解更多信息，請訪問網站或在X和LinkedIn上關注我們。
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
Optinose投資者聯繫人
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
Source: Optinose, Inc.
消息來源：Optinose，Inc.
